Ug99
Ug99 is a highly virulent strain of the wheat stem rust pathogen, Puccinia graminis f. sp. tritici. It was first identified in Uganda in 1999, hence the name Ug99. This strain poses a significant threat to global wheat production due to its ability to overcome many of the resistance genes that have been bred into wheat varieties over the past several decades.
Discovery and Spread
Ug99 was first discovered in Uganda in 1999 by scientists monitoring wheat crops for disease. Since its discovery, Ug99 has spread to several countries in East Africa, including Kenya, Ethiopia, and Sudan. The pathogen has also been reported in Yemen and Iran, raising concerns about its potential to spread to major wheat-producing regions in Asia and beyond.
Characteristics
Ug99 is particularly dangerous because it can overcome a wide range of resistance genes in wheat. Many of the wheat varieties grown worldwide possess the Sr31 resistance gene, which was effective against most strains of wheat stem rust until the emergence of Ug99. However, Ug99 has shown the ability to overcome Sr31, as well as several other resistance genes, making it a formidable threat to wheat crops.
Impact on Agriculture
The spread of Ug99 has significant implications for global food security. Wheat is a staple crop for millions of people around the world, and a major outbreak of stem rust could lead to severe reductions in wheat yields. This, in turn, could lead to higher food prices and increased risk of hunger and malnutrition in vulnerable populations.
Research and Management
Efforts to combat Ug99 include the development of new wheat varieties with resistance to the pathogen. Researchers are working to identify and incorporate new resistance genes into wheat breeding programs. Additionally, international collaborations, such as the Borlaug Global Rust Initiative, have been established to monitor the spread of Ug99 and develop strategies to mitigate its impact.
See Also
References
External Links
This article is a plant disease stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD